New Insights into Fluoroquinolone Resistance in Mycobacterium tuberculosis: Functional Genetic Analysis of gyrA and gyrB Mutations
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New Insights into Fluoroquinolone Resistance in Mycobacterium tuberculosis: Functional Genetic Analysis of gyrA and gyrB Mutations
Authors
Keywords
-
Journal
PLoS One
Volume 7, Issue 6, Pages e39754
Publisher
Public Library of Science (PLoS)
Online
2012-06-29
DOI
10.1371/journal.pone.0039754
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Extending the Definition of the GyrB Quinolone Resistance-Determining Region in Mycobacterium tuberculosis DNA Gyrase for Assessing Fluoroquinolone Resistance in M. tuberculosis
- (2012) Alix Pantel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system
- (2012) Fernanda Maruri et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Impact of the E540V Amino Acid Substitution in GyrB ofMycobacterium tuberculosison Quinolone Resistance
- (2011) Hyun Kim et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- DNA Gyrase Inhibition Assays Are Necessary To Demonstrate Fluoroquinolone Resistance Secondary togyrBMutations in Mycobacterium tuberculosis
- (2011) Alix Pantel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Molecular Detection of Mutations Associated with First- and Second-Line Drug Resistance Compared with Conventional Drug Susceptibility Testing of Mycobacterium tuberculosis
- (2011) Patricia J. Campbell et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Association of mutation patterns in gyrA/B genes and ofloxacin resistance levels in Mycobacterium tuberculosisisolates from East China in 2009
- (2011) Zhenling Cui et al. BMC INFECTIOUS DISEASES
- Population-based investigation of fluoroquinolones resistant tuberculosis in rural eastern China
- (2011) Yi Hu et al. TUBERCULOSIS
- Molecular Characterization of Fluoroquinolone Resistance inMycobacterium tuberculosis: Functional Analysis ofgyrAMutation at Position 74
- (2010) Ricky W. T. Lau et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Should Moxifloxacin Be Used for the Treatment of Extensively Drug-Resistant Tuberculosis? An Answer from a Murine Model
- (2010) J. Poissy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Rapid Detection of Fluoroquinolone-Resistant and Heteroresistant Mycobacterium tuberculosis by Use of Sloppy Molecular Beacons and Dual Melting-Temperature Codes in a Real-Time PCR Assay
- (2010) S. Chakravorty et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Mutation characterization of gyrA and gyrB genes in levofloxacin-resistant Mycobacterium tuberculosis clinical isolates from Guangdong Province in China
- (2010) Xiaomao Yin et al. JOURNAL OF INFECTION
- Evaluation of a line probe assay for the rapid detection of gyrA mutations associated with fluoroquinolone resistance in multidrug-resistant Mycobacterium tuberculosis
- (2010) H. Ando et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Structural Insights into the Quinolone Resistance Mechanism of Mycobacterium tuberculosis DNA Gyrase
- (2010) Jérémie Piton et al. PLoS One
- The Population Dynamics and Control of Tuberculosis
- (2010) C. Dye et al. SCIENCE
- Beijing Genotype of Mycobacterium tuberculosis Is Significantly Associated with High-Level Fluoroquinolone Resistance in Vietnam
- (2009) D. D. An et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Balancing Act: Efflux/Influx in Mycobacterial Drug Resistance
- (2009) G. E. Louw et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Sequence Analyses of Just Four Genes To Detect Extensively Drug-Resistant Mycobacterium tuberculosis Strains in Multidrug-Resistant Tuberculosis Patients Undergoing Treatment
- (2009) S. Feuerriegel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Fluoroquinolones for Treatment of Community‐Acquired Pneumonia and Tuberculosis: Putting the Risk of Resistance into Perspective
- (2009) Donald E. Low CLINICAL INFECTIOUS DISEASES
- Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial
- (2009) Marcus B Conde et al. LANCET
- Structural insight into the quinolone–DNA cleavage complex of type IIA topoisomerases
- (2009) Ivan Laponogov et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Mutations at embB Codon 306 Are an Important Molecular Indicator of Ethambutol Resistance in Mycobacterium tuberculosis
- (2008) A. M. Starks et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Molecular Characterization of Ofloxacin-Resistant Mycobacterium tuberculosis Strains from Russia
- (2008) I. Mokrousov et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started